Endoscopic ultrasound (EUS) is a useful imaging modality in patients with certain gastrointestinal malignancies as well as lung cancer. In many cases, EUS has been shown to have superior staging accuracy compared with other imaging techniques such as computed tomography, magnetic resonance imaging and positron emission tomography. This article will review the role of EUS in diagnosing and staging esophageal, rectal, pancreatic and lung cancers as well as subepithelial lesions. Newer therapeutic applications of EUS, namely endoscopic mucosal resection for removal of localized lesions as well as celiac plexus neurolysis for pain control, will also be discussed.

Keywords:
Endoscopic ultrasound, Esophageal cancer, Rectal cancer, Subepithelial lesions, Pancreatic cancer, Lung cancer, Endoscopic mucosal resection, Celiac plexus neurolysis
1.
Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462–467.
2.
Slater MS, Holland J, Faigel DO, Sheppard BC, Deveney CW: Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 2001;181:440–444.
3.
Frizzell B, Sinha D, Williams T, Reed CE, Sherman CA, Turrisi A: Influence of celiac axis lymph nodes in the definitive treatment of esophageal cancer. Am J Clin Oncol 2003;26:215–220.
4.
Tio TL, Cohen P, Coene PP, Udding J, den Hartog Jager FC, Tytgat GN: Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new (1987) TNM system. Gastroenterology 1989;96:1478–1486.
5.
Bhutani MS, Hawes RH, Hoffman BJ: A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc 1997;45:474–479.
6.
Catalano MF, Van Dam J, Sivak MV Jr: Malignant esophageal strictures: Staging accuracy of endoscopic ultrasonography. Gastrointest Endosc 1995;41:535–539.
7.
Van Dam J, Rice TW, Catalano MF, Kirby T, Sivak MV Jr: High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation. Cancer 1993;71:2910–2917.
8.
Pfau PR, Ginsberg GG, Lew RJ, Faigel DO, Smith DB, Kochman ML: Esophageal dilation for endosonographic evaluation of malignant esophageal strictures is safe and effective. Am J Gastroenterol 2000;95:2813–2815.
9.
Wallace MB, Hawes RH, Sahai AV, Van Velse A, Hoffman BJ: Dilation of malignant esophageal stenosis to allow EUS guided fine-needle aspiration: Safety and effect on patient management. Gastrointest Endosc 2000;51:309–313.
10.
Dittler HJ, Siewert JR: Role of endoscopic ultrasonography in esophageal carcinoma. Endoscopy 1993;25:156–161.
11.
Murata Y, Suzuki S, Hashimoto H: Endoscopic ultrasonography of the upper gastrointestinal tract. Surg Endosc 1988;2:180–183.
12.
Tio TL, Coene PP, den Hartog Jager FC, Tytgat GN: Preoperative TNM classification of esophageal carcinoma by endosonography. Hepatogastroenterology 1990;37:376–381.
13.
Grimm H, Binmoeller KF, Hamper K, Koch J, Henne-Bruns D, Soehendra N: Endosonography for preoperative locoregional staging of esophageal and gastric cancer. Endoscopy 1993;25:224–230.
14.
Rösch T, Classen M: Staging esophageal cancer, the Munich experience; in Van Dam J, Sivak M (eds): Gastrointestinal Endosonography. Philadelphia, Saunders, 1999, pp 139–145.
15.
Pfau PR, Ginsberg GG, Lew RJ, Brensinger CM, Kochman ML: EUS predictors of long-term survival in esophageal carcinoma. Gastrointest Endosc 2001;53:463–469.
16.
Frykholm GJ, Glimelius B, Pahlman L: Preoperative or postoperative irradiation in adenocarcinoma of the rectum: Final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36:564–572.
17.
Anonymous: NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444–1450.
18.
Savides TJ, Master SS: EUS in rectal cancer. Gastrointest Endosc 2002;56:S12–S18.
19.
Harewood GC, Wiersema MJ, Nelson H, Maccarty RL, Olson JE, Clain JE, Ahlquist DA, Jondal ML: A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer. Gastroenterology 2002;123:24–32.
20.
Herzog U, von Flue M, Tondelli P, Schuppisser JP: How accurate is endorectal ultrasound in the preoperative staging of rectal cancer? Dis Colon Rectum 1993;36:127–134.
21.
Rifkin MD, Ehrlich SM, Marks G: Staging of rectal carcinoma: Prospective comparison of endorectal US and CT. Radiology 1989;170:319–322.
22.
Kwok H, Bissett IP, Hill GL: Preoperative staging of rectal cancer. Int J Colorectal Dis 2000;15:9–20.
23.
Thaler W, Watzka S, Martin F, La Guardia G, Psenner K, Bonatti G, Fichtel G, Egarter-Vigl E, Marzoli GP: Preoperative staging of rectal cancer by endoluminal ultrasound vs. magnetic resonance imaging. Preliminary results of a prospective, comparative study. Dis Colon Rectum 1994;37:1189–1193.
24.
Waizer A, Powsner E, Russo I, Hadar S, Cytron S, Lombrozo R, Wolloch Y, Antebi E: Prospective comparative study of magnetic resonance imaging versus transrectal ultrasound for preoperative staging and follow-up of rectal cancer. Preliminary report. Dis Colon Rectum 1991;34:1068–1072.
25.
Gualdi GF, Casciani E, Guadalaxara A, d’Orta C, Polettini E, Pappalardo G: Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: Comparison with histologic findings. Dis Colon Rectum 2000;43:338–345.
26.
Meyenberger C, Huch Boni RA, Bertschinger P, Zala GF, Klotz HP, Krestin GP: Endoscopic ultrasound and endorectal magnetic resonance imaging: A prospective, comparative study for preoperative staging and follow-up of rectal cancer. Endoscopy 1995;27:469–479.
27.
Shami VM, Parmar KS, Waxman I: Clinical impact of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration in the management of rectal carcinoma. Dis Colon Rectum 2004;47:59–65.
28.
Harewood GC: Assessment of clinical impact of endoscopic ultrasound on rectal cancer. Am J Gastroenterol 2004;99:623–627.
29.
Kahn H, Alexander A, Rakinic J, Nagle D, Fry R: Preoperative staging of irradiated rectal cancers using digital rectal examination, computed tomography, endorectal ultrasound, and magnetic resonance imaging does not accurately predict T0,N0 pathology. Dis Colon Rectum 1997;40:140–144.
30.
Lindmark GE, Kraaz WG, Elvin PA, Glimelius BL: Rectal cancer: Evaluation of staging with endosonography. Radiology 1997;204:533–538.
31.
Rau B, Hunerbein M, Barth C, Wust P, Haensch W, Riess H, Felix R, Schlag PM: Accuracy of endorectal ultrasound after preoperative radiochemotherapy in locally advanced rectal cancer. Surg Endosc 1999;13:980–984.
32.
Vanagunas A, Lin DE, Stryker SJ: Accuracy of endoscopic ultrasound for restaging rectal cancer following neoadjuvant chemoradiation therapy. Am J Gastroenterol 2004;99:109–112.
33.
Williamson PR, Hellinger MD, Larach SW, Ferrara A: Endorectal ultrasound of T3 and T4 rectal cancers after preoperative chemoradiation. Dis Colon Rectum 1996;39:45–49.
34.
Rotondano G, Esposito P, Pellecchia L, Novi A, Romano G: Early detection of locally recurrent rectal cancer by endosonography. Br J Radiol 1997;70:567–571.
35.
Novell F, Pascual S, Viella P, Trias M: Endorectal ultrasonography in the follow-up of rectal cancer. Is it a better way to detect early local recurrence? Int J Colorectal Dis 1997;12:78–81.
36.
Lohnert MS, Doniec JM, Henne-Bruns D: Effectiveness of endoluminal sonography in the identification of occult local rectal cancer recurrences. Dis Colon Rectum 2000;43:483–491.
37.
Hunerbein M, Totkas S, Moesta KT, Ulmer C, Handke T, Schlag PM: The role of transrectal ultrasound-guided biopsy in the postoperative follow-up of patients with rectal cancer. Surgery 2001;129:164–169.
38.
Rösch T, Braig C, Gain T, Feuerbach S, Siewert JR, Schusdziarra V, Classen M: Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 1992;102:188–199.
39.
Palazzo L, Roseau G, Gayet B, Vilgrain V, Belghiti J, Fekete F, Paolaggi JA: Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy 1993;25:143–150.
40.
Tio TL, Tytgat GN, Cikot RJ, Houthoff HJ, Sars PR: Ampullopancreatic carcinoma: Preoperative TNM classification with endosonography. Radiology 1990;175:455–461.
41.
Snady H, Cooperman A, Siegel J: Endoscopic ultrasonography compared with computed tomography with ERCP in patients with obstructive jaundice or small peri-pancreatic mass. Gastrointest Endosc 1992;38:27–34.
42.
Muller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B: Pancreatic tumors: Evaluation with endoscopic US, CT, and MR imaging. Radiology 1994;190:745–751.
43.
Gress FG, Hawes RH, Savides TJ, Ikenberry SO, Cummings O, Kopecky K, Sherman S, Wiersema M, Lehman GA: Role of EUS in the preoperative staging of pancreatic cancer: A large single-center experience. Gastrointest Endosc 1999;50:786–791.
44.
O’Toole D, Palazzo L, Arotcarena R, Dancour A, Aubert A, Hammel P, Amaris J, Ruszniewski P: Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc 2001;53:470–474.
45.
Williams DB, Sahai AV, Aabakken L, Penman ID, van Velse A, Webb J, Wilson M, Hoffman BJ, Hawes RH: Endoscopic ultrasound guided fine needle aspiration biopsy: A large single centre experience. Gut 1999;44:720–726.
46.
Raut CP, Grau AM, Staerkel GA, Kaw M, Tamm EP, Wolff RA, Vauthey JN, Lee JE, Pisters PW, Evans DB: Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg 2003;7:118–126; discussion 127–128.
47.
Shin HJ, Lahoti S, Sneige N: Endoscopic ultrasound-guided fine-needle aspiration in 179 cases: The M D Anderson Cancer Center experience. Cancer 2002;96:174–180.
48.
Walsh DC, Ylagan L, Kassal K, Lu D, Edmundowicz S: EUS-FNA of suspected pancreatic adenocarcinoma: Does multiple pass FNA eliminate the need for a cytopathologist in the procedure room (abstract)? Gastrointest Endosc 2002;55:AB248.
49.
Bret PM, Nicolet V, Labadie M: Percutaneous fine-needle aspiration biopsy of the pancreas. Diagn Cytopathol 1986;2:221–227.
50.
Bergenfeldt M, Genell S, Lindholm K, Ekberg O, Aspelin P: Needle-tract seeding after percutaneous fine-needle biopsy of pancreatic carcinoma. Case report. Acta Chir Scand 1988;154:77–79.
51.
Lee JG, Leung JW, Baillie J, Layfield LJ, Cotton PB: Benign, dysplastic, or malignant – Making sense of endoscopic bile duct brush cytology: Results in 149 consecutive patients. Am J Gastroenterol 1995;90:722–726.
52.
Ponchon T, Gagnon P, Berger F, Labadie M, Liaras A, Chavaillon A, Bory R: Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: Results of a prospective study. Gastrointest Endosc 1995;42:565–572.
53.
Gress F, Gottlieb K, Sherman S, Lehman G: Endoscopic ultrasonography-guided fine-needle aspiration biopsy of suspected pancreatic cancer. Ann Intern Med 2001;134:459–464.
54.
Harewood GC, Wiersema MJ: Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am J Gastroenterol 2002;97:1386–1391.
55.
Kaneko K, Honda H, Hayashi T, Fukuya T, Ro T, Irie H, Masuda K: Helical CT evaluation of arterial invasion in pancreatic tumors: Comparison with angiography. Abdom Imaging 1997;22:204–207.
56.
Schwarz M, Pauls S, Sokiranski R, Brambs HJ, Glasbrenner B, Adler G, Diederichs CG, Reske SN, Moller P, Beger HG: Is a preoperative multidiagnostic approach to predict surgical resectability of periampullary tumors still effective? Am J Surg 2001;182:243–249.
57.
Mertz HR, Sechopoulos P, Delbeke D, Leach SD: EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc 2000;52:367–371.
58.
Midwinter MJ, Beveridge CJ, Wilsdon JB, Bennett MK, Baudouin CJ, Charnley RM: Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 1999;86:189–193.
59.
Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L: Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol 2004;99:844–850.
60.
Tierney WM, Francis IR, Eckhauser F, Elta G, Nostrant TT, Scheiman JM: The accuracy of EUS and helical CT in the assessment of vascular invasion by peripapillary malignancy. Gastrointest Endosc 2001;53:182–188.
61.
Legmann P, Vignaux O, Dousset B, Baraza AJ, Palazzo L, Dumontier I, Coste J, Louvel A, Roseau G, Couturier D, Bonnin A: Pancreatic tumors: Comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998;170:1315–1322.
62.
Hunt GC, Faigel DO: Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: A review. Gastrointest Endosc 2002;55:232–237.
63.
Rösch T, Dittler HJ, Strobel K, Meining A, Schusdziarra V, Lorenz R, Allescher HD, Kassem AM, Gerhardt P, Siewert JR, Hofler H, Classen M: Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: A blind reevaluation of videotapes. Gastrointest Endosc 2000;52:469–477.
64.
Ahmad NA, Lewis JD, Ginsberg GG, Rosato EF, Morris JB, Kochman ML: EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc 2000;52:463–468.
65.
Anderson MA, Carpenter S, Thompson NW, Nostrant TT, Elta GH, Scheiman JM: Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 2000;95:2271–2277.
66.
Bansal R, Tierney W, Carpenter S, Thompson N, Scheiman JM: Cost effectiveness of EUS for preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 1999;49:19–25.
67.
Herder GJ, Verboom P, Smit EF, van Velthoven PC, van den Bergh JH, Colder CD, van Mansom I, van Mourik JC, Postmus PE, Teule GJ, Hoekstra OS: Practice, efficacy and cost of staging suspected non-small cell lung cancer: A retrospective study in two Dutch hospitals. Thorax 2002;57:11–14.
68.
McKenna RJ Jr, Libshitz HI, Mountain CE, McMurtrey MJ: Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer. Chest 1985;88:206–210.
69.
McLoud TC, Bourgouin PM, Greenberg RW, Kosiuk JP, Templeton PA, Shepard JA, Moore EH, Wain JC, Mathisen DJ, Grillo HC: Bronchogenic carcinoma: Analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992;182:319–323.
70.
Prenzel KL, Monig SP, Sinning JM, Baldus SE, Brochhagen HG, Schneider PM, Holscher AH: Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 2003;123:463–467.
71.
Fritscher-Ravens A, Bohuslavizki KH, Brandt L, Bobrowski C, Lund C, Knofel WT, Pforte A: Mediastinal lymph node involvement in potentially resectable lung cancer: Comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration. Chest 2003;123:442–451.
72.
Kramer H, Groen HJ: Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer. Ann Surg 2003;238:180–188.
73.
Fritscher-Ravens A, Soehendra N, Schirrow L, Sriram PV, Meyer A, Hauber HP, Pforte A: Role of transesophageal endosonography-guided fine-needle aspiration in the diagnosis of lung cancer. Chest 2000;117:339–345.
74.
Larsen SS, Krasnik M, Vilmann P, Jacobsen GK, Pedersen JH, Faurschou P, Folke K: Endoscopic ultrasound guided biopsy of mediastinal lesions has a major impact on patient management. Thorax 2002;57:98–103.
75.
Parmar K, Waxman I: Endosonography of submucosal lesions. Tech Gastrointest Endosc 2000;2:89–93.
76.
DeMatteo RP: The GIST of targeted cancer therapy: A tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571). Ann Surg Oncol 2002;9:831–839.
77.
Chak A, Canto MI, Rosch T, Dittler HJ, Hawes RH, Tio TL, Lightdale CJ, Boyce HW, Scheiman J, Carpenter SL, Van Dam J, Kochman ML, Sivak MV Jr: Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc 1997;45:468–473.
78.
Dagher R, Cohen M, Williams G, Rothmann M, Gobburu J, Robbie G, Rahman A, Chen G, Staten A, Griebel D, Pazdur R: Approval summary: Imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res 2002;8:3034–3038.
79.
Ventafridda GV, Caraceni AT, Sbanotto AM, Barletta L, De Conno F: Pain treatment in cancer of the pancreas. Eur J Surg Oncol 1990;16:1–6.
80.
Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F: A validation study of the WHO method for cancer pain relief. Cancer 1987;59:850–856.
81.
Eisenberg E, Carr DB, Chalmers TC: Neurolytic celiac plexus block for treatment of cancer pain: A meta-analysis. Anesth Analg 1995;80:290–295.
82.
Hayakawa J, Kobayashi O, Murayama H: Paraplegia after intraoperative celiac plexus block. Anesth Analg 1997;84:447–448.
83.
Gunaratnam NT, Sarma AV, Norton ID, Wiersema MJ: A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest Endosc 2001;54:316–324.
84.
Soetikno RM, Gotoda T, Nakanishi Y, Soehendra N: Endoscopic mucosal resection. Gastrointest Endosc 2003;57:567–579.
85.
Inoue H, Takeshita K, Hori H, Muraoka Y, Yoneshima H, Endo M: Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc 1993;39:58–62.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.